We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+20.36%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$88.3B
AUM Growth
+$11B
(+14%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
29.94%
Holding
1,471
New
79
Increased
623
Reduced
633
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$185M |
| 2 |
Clorox
CLX
|
+$182M |
| 3 |
Hershey
HSY
|
+$170M |
| 4 |
PepsiCo
PEP
|
+$169M |
| 5 |
Lam Research
LRCX
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$252M |
| 2 |
Veeva Systems
VEEV
|
+$238M |
| 3 |
Gilead Sciences
GILD
|
+$227M |
| 4 |
Altria Group
MO
|
+$209M |
| 5 |
Equifax
EFX
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.08% |
| 2 | Materials | 23.94% |
| 3 | Industrials | 7.62% |
| 4 | Healthcare | 6.11% |
| 5 | Financials | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Guardant Health
GH
$21.4B
| $147K | ﹤0.01% |
2,832
+448
| +19% | +$20K |
|
1277
Equitable Holdings
EQH
$14.4B
| $146K | ﹤0.01% |
2,596
-302
| -10% | -$15.5K |
|
1278
Glaukos
GKOS
$11.2B
| $145K | ﹤0.01% |
1,399
-10
| -0.7% | -$938 |
|
1279
Corebridge Financial
CRBG
$15.3B
| $142K | ﹤0.01% |
4,007
+428
| +12% | +$13.3K |
|
1280
NGL Energy Partners
NGL
$2.13B
| $138K | ﹤0.01% |
32,206
-1,341
| -4% | -$4.81K |
|
1281
Principal Financial Group
PFG
$24.6B
| $137K | ﹤0.01% |
+1,720
| New | +$132K |
|
1282
Herbalife
HLF
$1.28B
| $134K | ﹤0.01% |
15,578
+3,116
| +25% | +$23.1K |
|
1283
Onto Innovation
ONTO
$20.6B
| $134K | ﹤0.01% |
1,329
+560
| +73% | +$59.8K |
|
1284
Colgate-Palmolive
CL
$74.1B
| $133K | ﹤0.01% |
1,466
| – | – |
|
1285
Integer Holdings
ITGR
$4.25B
| $133K | ﹤0.01% |
1,083
-47
| -4% | -$5.61K |
|
|
BPMC
1286
DELISTED
Blueprint Medicines
BPMC
| $129K | ﹤0.01% |
1,004
-112
| -10% | -$11.6K |
|
1287
Envista
NVST
$4.51B
| $129K | ﹤0.01% |
6,616
-1,041
| -14% | -$18.1K |
|
1288
Vinci Compass Investments Ltd
VINP
$623M
| $125K | ﹤0.01% |
12,917
+363
| +3% | +$3.5K |
|
1289
Transmedics
TMDX
$3.11B
| $122K | ﹤0.01% |
913
-1,100
| -55% | -$121K |
|
1290
Tandem Diabetes Care
TNDM
$1.61B
| $122K | ﹤0.01% |
6,541
-857
| -12% | -$17K |
|
1291
Cognex
CGNX
$10.4B
| $120K | ﹤0.01% |
3,793
-138,527
| -97% | -$3.97M |
|
1292
KeyCorp
KEY
$24.6B
| $117K | ﹤0.01% |
+6,740
| New | +$104K |
|
1293
Perion Network
PERI
$384M
| $117K | ﹤0.01% |
11,511
-5,471
| -32% | -$52.3K |
|
1294
Invesco
IVZ
$14.3B
| $116K | ﹤0.01% |
7,359
-248
| -3% | -$3.56K |
|
|
STKL
1295
DELISTED
SunOpta
STKL
| $113K | ﹤0.01% |
19,529
+239
| +1% | +$1.25K |
|
1296
Dr. Reddy's Laboratories
RDY
$10.3B
| $112K | ﹤0.01% |
7,474
+1,388
| +23% | +$19.8K |
|
1297
Vitamin Cottage Natural Grocers
NGVC
$646M
| $111K | ﹤0.01% |
2,816
+286
| +11% | +$13.2K |
|
|
OTLY
1298
Oatly Group
OTLY
$441M
| $110K | ﹤0.01% |
9,245
-915
| -9% | -$9.65K |
|
|
TLN
1299
Talen Energy Corp
TLN
$17.2B
| $105K | ﹤0.01% |
+360
| New | +$85.4K |
|
1300
Alphatec Holdings
ATEC
$1.51B
| $104K | ﹤0.01% |
9,411
-2,503
| -21% | -$28.8K |
|
Similar funds
VanEck Associates's Q2 2025 Portfolio in Review
As of Q2 2025, VanEck Associates held 1,471 positions worth $88.3B, up 14% from $77.4B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
VanEck Associates's Q2 2025 filing shows 79 new, 623 increased, 633 reduced and 76 closed positions. Its largest new stake was Nordson: 762,014 shares worth $163M. The largest sale was Corteva, an estimated $252M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 37% a quarter earlier, followed by Materials and Industrials.
- VanEck Associates's largest Q2 2025 buy was Nordson: 762,014 shares worth $163M.
- VanEck Associates added most to Applied Materials in Q2 2025, an estimated $185M increase.
- VanEck Associates's biggest Q2 2025 reduction was Corteva, cutting an estimated $252M.
- VanEck Associates fully exited US Steel in Q2 2025, selling an estimated $26.8M.
- VanEck Associates's ten largest holdings make up 30% of its $88.3B portfolio in Q2 2025.
- VanEck Associates opened 79 new positions and closed 76 in Q2 2025.
- VanEck Associates's portfolio value rose 14% quarter-over-quarter to $88.3B.
Based on VanEck Associates's 13F filing for Q2 2025, filed 14 Aug 2025.